{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:51:00Z","timestamp":1742392260005},"reference-count":29,"publisher":"The Editorial Committee of Annals of Vascular Diseases","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Vascular Diseases","AVD","Ann Vasc Dis"],"published-print":{"date-parts":[[2012]]},"DOI":"10.3400\/avd.ra.12.00062","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T08:12:02Z","timestamp":1348647122000},"page":"289-295","source":"Crossref","is-referenced-by-count":4,"title":["Genetics of Microscopic Polyangiitis in the Japanese Population"],"prefix":"10.3400","volume":"5","author":[{"given":"Naoyuki","family":"Tsuchiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1983","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.Kallenberg CG, Rarok A, Stegeman CA, et al.New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. Autoimmun Rev2002; <b>1<\/b>: 61-6.","DOI":"10.1016\/S1568-9972(01)00008-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.Meyer MF, Hellmich B, Kotterba S, et al.Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection?Rheumatol Int2000; <b>20<\/b>: 35-8.","DOI":"10.1007\/s002960000063"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3.Spencer SJ, Burns A, Gaskin G, et al.HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int1992; <b>41<\/b>: 1059-63.","DOI":"10.1038\/ki.1992.161"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4.Gencik M, Borgmann S, Zahn R, et al.Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol1999; <b>117<\/b>: 412-7.","DOI":"10.1046\/j.1365-2249.1999.00969.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5.Papiha SS, Murty GE, Ad&rsquo;Hia A, et al. Association of Wegener&rsquo;s granulomatosis with HLA antigens and other genetic markers. Ann Rheum Dis1992; <b>51<\/b>: 246-8.","DOI":"10.1136\/ard.51.2.246"},{"key":"6","unstructured":"6.Nakamaru Y, Maguchi S, Takizawa M, et al.The association between human leukocyte antigens (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener&rsquo;s granulomatosis in a Japanese population. Rhinology1996; <b>34<\/b>: 163-5."},{"key":"7","unstructured":"7.Fujii A, Tomizawa K, Arimura Y, et al.Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis. Clin Nephrol2000; <b>53<\/b>: 242-52."},{"key":"8","unstructured":"8.Tsuchiya N, Kobayashi S, Kawasaki A, et al.Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol2003; <b>30<\/b>: 1534-40."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.Tsuchiya N, Kobayashi S, Hashimoto H, et al.Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun2006; <b>7<\/b>: 81-4.","DOI":"10.1038\/sj.gene.6364262"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10.Matsuki K, Juji T, Tokunaga K, et al.HLA antigens in Japanese patients with myasthenia gravis. J Clin Invest1990; <b>86<\/b>: 392-9.","DOI":"10.1172\/JCI114724"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11.Kawabata Y, Ikegami H, Kawaguchi Y, et al.Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes2002; <b>51<\/b>: 545-51.","DOI":"10.2337\/diabetes.51.2.545"},{"key":"12","unstructured":"12.Hashimoto H, Yamanaka K, Tokano Y, et al.HLA-DRB1 alleles and beta 2 glycoprotein I-dependent anticardiolipin antibodies in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumatol1998; <b>16<\/b>: 423-7."},{"key":"13","unstructured":"13.Furuya T, Hakoda M, Ichikawa N, et al.Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Clin Exp Rheumatol2007; <b>25<\/b>: 219-24."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14.Ljunggren HG, Karre K. In search of the &lsquo;missing self&rsquo;: MHC molecules and NK cell recognition. Immunol Today1990; <b>11<\/b>: 237-44.","DOI":"10.1016\/0167-5699(90)90097-S"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15.Kikuchi-Maki A, Catina TL, Campbell KS. Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. J Immunol2005; <b>174<\/b>: 3859-63.","DOI":"10.4049\/jimmunol.174.7.3859"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16.Williams AP, Bateman AR, Khakoo SI. Hanging in the balance. KIR and their role in disease. Mol Interv2005; <b>5<\/b>: 226-40.","DOI":"10.1124\/mi.5.4.6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17.Tsuchiya N, Kyogoku C, Miyashita R, et al.Diversity of human immune system multigene families and its implication in the genetic background of rheumatic diseases. Curr Med Chem2007; <b>14<\/b>: 431-9.","DOI":"10.2174\/092986707779941041"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18.Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin Immunol2008; <b>20<\/b>: 343-52.","DOI":"10.1016\/j.smim.2008.06.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19.Martin MP, Gao X, Lee JH, et al.Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet2002; <b>31<\/b>: 429-34.","DOI":"10.1038\/ng934"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20.Khakoo SI, Thio CL, Martin MP, et al.HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science2004; <b>305<\/b>: 872-4.","DOI":"10.1126\/science.1097670"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21.Carrington M, Wang S, Martin MP, et al.Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med2005; <b>201<\/b>: 1069-75.","DOI":"10.1084\/jem.20042158"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22.Yen JH, Lin CH, Tsai WC, et al.Killer cell immunoglobulin-like receptor gene&rsquo;s repertoire in rheumatoid arthritis. Scand J Rheumatol2006; <b>35<\/b>: 124-7.","DOI":"10.1080\/03009740500381252"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23.Suzuki Y, Hamamoto Y, Ogasawara Y, et al.Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol2004; <b>122<\/b>: 1133-6.","DOI":"10.1111\/j.0022-202X.2004.22517.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24.Nelson GW, Martin MP, Gladman D, et al.Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol2004; <b>173<\/b>: 4273-6.","DOI":"10.4049\/jimmunol.173.7.4273"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25.van der Slik AR, Koeleman BP, Verduijn W, et al.KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes2003; <b>52<\/b>: 2639-42.","DOI":"10.2337\/diabetes.52.10.2639"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26.Momot T, Koch S, Hunzelmann N, et al.Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum2004; <b>50<\/b>: 1561-5.","DOI":"10.1002\/art.20216"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27.Gazit R, Garty BZ, Monselise Y, et al.Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood2004; <b>103<\/b>: 1965-6.","DOI":"10.1182\/blood-2003-11-3796"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28.Miyashita R, Tsuchiya N, Yabe T, et al.Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. Arthritis Rheum2006; <b>54<\/b>: 992-7.","DOI":"10.1002\/art.21653"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29.Mamegano K, Kuroki K, Miyashita R, et al.Association of LILRA2 (ILT1, LIR7) splice site polymorphism with systemic lupus erythematosus and microscopic polyangiitis. Genes Immun2008; <b>9<\/b>: 214-23.","DOI":"10.1038\/gene.2008.5"}],"container-title":["Annals of Vascular Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T06:31:09Z","timestamp":1562221869000},"score":1,"resource":{"primary":{"URL":"http:\/\/japanlinkcenter.org\/DN\/JST.JSTAGE\/avd\/ra.12.00062?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.3400\/avd.ra.12.00062","relation":{},"ISSN":["1881-641X","1881-6428"],"issn-type":[{"value":"1881-641X","type":"print"},{"value":"1881-6428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}